Amalgamated Bank’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,272
| Closed | -$7K | – | 3195 |
|
|
2025
Q1 | $7K | Hold |
1,272
| – | – | ﹤0.01% | 2559 |
|
|
2024
Q4 | $5K | Hold |
1,272
| – | – | ﹤0.01% | 2769 |
|
|
2024
Q3 | $7K | Hold |
1,272
| – | – | ﹤0.01% | 2658 |
|
|
2024
Q2 | $11K | Hold |
1,272
| – | – | ﹤0.01% | 2417 |
|
|
2024
Q1 | $18K | Sell |
1,272
-2,560
| -67% | -$42.3K | ﹤0.01% | 2182 |
|
|
2023
Q4 | $82K | Sell |
3,832
-378
| -9% | -$6.75K | ﹤0.01% | 2065 |
|
|
2023
Q3 | $81K | Hold |
4,210
| – | – | ﹤0.01% | 2076 |
|
|
2023
Q2 | $107K | Sell |
4,210
-737
| -15% | -$21.3K | ﹤0.01% | 2040 |
|
|
2023
Q1 | $179K | Sell |
4,947
-637
| -11% | -$22.4K | ﹤0.01% | 1844 |
|
|
2022
Q4 | $221K | Hold |
5,584
| – | – | ﹤0.01% | 1824 |
|
|
2022
Q3 | $260K | Buy |
5,584
+87
| +2% | +$4.04K | ﹤0.01% | 1749 |
|
|
2022
Q2 | $241K | Sell |
5,497
-168
| -3% | -$9.24K | ﹤0.01% | 1790 |
|
|
2022
Q1 | $410K | Sell |
5,665
-425
| -7% | -$30.6K | ﹤0.01% | 1637 |
|
|
2021
Q4 | $494K | Sell |
6,090
-65
| -1% | -$6.51K | ﹤0.01% | 1581 |
|
|
2021
Q3 | $716K | Sell |
6,155
-379
| -6% | -$49.6K | 0.01% | 1411 |
|
|
2021
Q2 | $1.08M | Buy |
6,534
+1,693
| +35% | +$264K | 0.01% | 1249 |
|
|
2021
Q1 | $675K | Sell |
4,841
-473
| -9% | -$77.2K | 0.03% | 805 |
|
|
2020
Q4 | $920K | Buy |
5,314
+92
| +2% | +$14.9K | 0.03% | 596 |
|
|
2020
Q3 | $727K | Sell |
5,222
-153
| -3% | -$20.4K | 0.03% | 634 |
|
|
2020
Q2 | $642K | Buy |
5,375
+70
| +1% | +$8.3K | 0.03% | 676 |
|
|
2020
Q1 | $530K | Sell |
5,305
-158
| -3% | -$19K | 0.01% | 879 |
|
|
2019
Q4 | $642K | Buy |
5,463
+241
| +5% | +$23.9K | 0.01% | 995 |
|
|
2019
Q3 | $449K | Sell |
5,222
-73
| -1% | -$5.52K | 0.01% | 1096 |
|
|
2019
Q2 | $343K | Buy |
5,295
+897
| +20% | +$55.9K | 0.01% | 1275 |
|
|
2019
Q1 | $275K | Buy |
+4,398
| New | +$207K | 0.01% | 1320 |
|
|
2018
Q3 | – | Sell |
-4,438
| Closed | -$354K | – | 1637 |
|
|
2018
Q2 | $354K | Buy |
4,438
+695
| +19% | +$57.7K | 0.01% | 1216 |
|
|
2018
Q1 | $324K | Sell |
3,743
-16
| -0.4% | -$1.29K | 0.01% | 1171 |
|
|
2017
Q4 | $260K | Buy |
3,759
+228
| +6% | +$18.2K | 0.01% | 1347 |
|
|
2017
Q3 | $321K | Sell |
3,531
-16
| -0.5% | -$1.37K | 0.01% | 1170 |
|
|
2017
Q2 | $264K | Buy |
3,547
+603
| +20% | +$48.3K | 0.01% | 1267 |
|
|
2017
Q1 | $276K | Sell |
2,944
-3
| -0.1% | -$272 | 0.01% | 1185 |
|
|
2016
Q4 | $214K | Buy |
2,947
+406
| +16% | +$34.8K | 0.01% | 1354 |
|
|
2016
Q3 | $265K | Buy |
2,541
+3
| +0.1% | +$271 | 0.02% | 1090 |
|
|
2016
Q2 | $247K | Buy |
+2,538
| New | +$172K | 0.01% | 1135 |
|
Other funds holding NVRO
Amalgamated Bank's NVRO Position: Q2 2025 in Review
Amalgamated Bank sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 1,272 shares — an estimated $7K sold.
Amalgamated Bank first reported a position in NVRO in Q2 2016 and held it in 34 quarters. The position peaked at $1.08M in Q2 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Amalgamated Bank reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Amalgamated Bank sold 1,272 NEVRO CORP. shares in Q2 2025, an estimated $7K.
- Amalgamated Bank first reported a position in NEVRO CORP. in Q2 2016 and held it in 34 quarters.
- Amalgamated Bank's NEVRO CORP. position peaked at $1.08M in Q2 2021.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.